Granules opened at ₹802.95, in line with its previous close of ₹803.35. During today's session, the stock has traded between ₹782.05 and ₹818.00, with an average traded price of ₹803.72. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Granules is now worth
₹ 24,686.00
giving a profit of
₹ 14,686.00 (146.86%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+11.15 (+1.39%)
Day High
₹818.00
Day Low
₹782.05
Day Open
₹802.95
Prev Close
₹803.35
Volume
8,13,974
Value Traded
₹65.42 Cr
1W Return
-0.34%
1M Return
-10.43%
3M Return
-8.47%
6M Return
28.89%
1Y Return
43.26%
Market Cap (₹ Cr.)
20,183
PE Ratio
33.00
PB Ratio
3.54
Dividend Yield
0.22%
ROE
11.70%
ROCE
15.98%
Book Value (₹)
226.59
Face Value (₹)
1.00
EPS (TTM)
7.26
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-0.34%
6 Week
-
1 Month
-10.43%
3 Month
-8.47%
9 Month
36.93%
Granules India uploads full transcript of Sep 29 transformation webinar
Complex generics now contribute 33% of revenue, up from 1% in FY20. Controlled substances business is the third largest in the US by value. Targeting $100 million revenue from peptide CDMO within five years. Planning ₹2,000 crore organic capex over next 3-4 years funded by net cash position.
7 days agoGranules India incorporates wholly owned subsidiary in Brazil
Incorporated Triton Farmaceutica do Brasil Ltda as a wholly owned subsidiary. Subsidiary to manufacture and distribute pharmaceuticals in Brazil. RBI approval obtained under the automatic route for the investment. Promoter and promoter group hold no interest in the new entity.
11 days agoGranules India promoter group acquires 9.12% stake via open market
Uma Devi Chigurupati acquired 2,48,80,342 shares of Granules India via open market. Stake increased from 3.81% to 12.51% of total voting capital. Transaction completed on September 16, 2026, under SEBI Regulation 29(2). Post-acquisition holding stands at 3,41,21,103 equity shares.
18 days agoGranules India to host analyst and investor meeting in New Delhi on Sep 28
Granules India Limited will host an analyst and investor meeting on September 28, 2026. The event is scheduled to take place in New Delhi. Management confirmed no unpublished price-sensitive information will be shared. The filing was made under Regulation 30 of SEBI LODR Regulations, 2015. Latest investor presentation is available on the company website.
20 days agoGranules India promoter sells 1.72 crore shares in block deal
Promoter Dr. Krishna Prasad Chigurupati sold 1,72,00,000 shares via block deal on September 11, 2026. Stake reduced from 31.00% to 24.06% of total voting capital. Institutional buyers included Capital Group, Kotak Life, and ChrysCapital. Post-sale holding stands at 5,96,08,111 shares (21.85% diluted).
1mo agoGranules India hosts analyst meet on September 18 in Hyderabad
Granules India hosts analyst meet on September 18, 2026. Session held in Hyderabad per SEBI LODR Regulation 30. No unpublished price-sensitive info to be shared. Schedule is tentative and subject to change.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Granules is now worth
₹ 24,686.00
giving a profit of
₹ 14,686.00 (146.86%)
Note: Past profits do not guarantee future returns.
